UB Paderborn / Katalog / Suche / in CDI

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv166-iv191

2018

Link zum Volltext

Verfügbarkeit prüfen

Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience

Clinical neuropharmacology, 2010-07, Vol.33 (4), p.179-180

2010

Link zum Volltext

Verfügbarkeit prüfen

Bone Metastasis Pain, from the Bench to the Bedside

International journal of molecular sciences, 2019-01, Vol.20 (2), p.280

2019

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research

BMJ supportive & palliative care, 2018-12, Vol.8 (4), p.456

2018

Link zum Volltext

Verfügbarkeit prüfen

Low Morphine Doses in Opioid-Naive Cancer Patients with Pain

Journal of pain and symptom management, 2006-03, Vol.31 (3), p.242-247

2006

Link zum Volltext

Verfügbarkeit prüfen

Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain

Journal of pain and symptom management, 2019-05, Vol.57 (5), p.966-970

2019

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS‐MS study

European journal of pain, 2019-04, Vol.23 (4), p.719-726

2019

Link zum Volltext

Verfügbarkeit prüfen

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings

Journal of pain and symptom management, 2015-12, Vol.50 (6), p.786-792

2015

Link zum Volltext

Verfügbarkeit prüfen

Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study

Journal of pain and symptom management, 2015-11, Vol.50 (5), p.579-586

2015

Link zum Volltext

Verfügbarkeit prüfen

Topical Morphine in the Treatment of Painful Ulcers

Journal of pain and symptom management, 2005-10, Vol.30 (4), p.304-305

2005

Link zum Volltext

Verfügbarkeit prüfen

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines††FootnotesApproved by the ESMO Guidelines Committee: December 2004, last update April 2018. This publication supersedes the previously published version—Ann Oncol 2012; 23(Suppl 7): vii139–vii154

Annals of oncology, 2018-10, Vol.29, p.iv166-iv191

2018

Link zum Volltext

Verfügbarkeit prüfen

Fentanyl Pectin Nasal Spray versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study

Journal of pain and symptom management, 2016-07, Vol.52 (1), p.27-34

2016

Link zum Volltext

Verfügbarkeit prüfen

Tapentadol in cancer pain management: a prospective open-label study

Current medical research and opinion, 2012-11, Vol.28 (11), p.1775-1779

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids

Supportive care in cancer, 2017-02, Vol.25 (2), p.645-649

2017

Link zum Volltext

Verfügbarkeit prüfen

Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses

Current medical research and opinion, 2012-06, Vol.28 (6), p.963-968

2012

Link zum Volltext

Verfügbarkeit prüfen

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting

Supportive care in cancer, 2013-08, Vol.21 (8), p.2335-2339

2013

Link zum Volltext

Verfügbarkeit prüfen

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

European journal of pain, 2008-11, Vol.12 (8), p.1040-1046

2008

Link zum Volltext

Verfügbarkeit prüfen

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

Current medical research and opinion, 2013-06, Vol.29 (6), p.661-666

2013

Link zum Volltext

Verfügbarkeit prüfen

Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain

Current medical research and opinion, 2014-10, Vol.30 (10), p.2063-2068

2014

Link zum Volltext

Verfügbarkeit prüfen

Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

Current medical research and opinion, 2013-06, Vol.29 (6), p.667-671

2013

Link zum Volltext

Verfügbarkeit prüfen

Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home

Drugs & aging, 2015-04, Vol.32 (4), p.315-320

2015

Link zum Volltext

Verfügbarkeit prüfen

Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients

The journal of pain, 2009-06, Vol.10 (6), p.594-600

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine

Journal of pain and symptom management, 2006-08, Vol.32 (2), p.175-179

2006

Link zum Volltext

Verfügbarkeit prüfen

Opioid Switching in Patients With Advanced Cancer Followed at Home. A Retrospective Analysis

Journal of pain and symptom management, 2013-02, Vol.45 (2), p.298-304

2013

Link zum Volltext

Verfügbarkeit prüfen

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 Suppl 4, p.iv166

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience

Bone Metastasis Pain, from the Bench to the Bedside

Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research

Low Morphine Doses in Opioid-Naive Cancer Patients with Pain

Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain

Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS‐MS study

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings

Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study

Topical Morphine in the Treatment of Painful Ulcers

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines††FootnotesApproved by the ESMO Guidelines Committee: December 2004, last update April 2018. This publication supersedes the previously published version—Ann Oncol 2012; 23(Suppl 7): vii139–vii154

Fentanyl Pectin Nasal Spray versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study

Tapentadol in cancer pain management: a prospective open-label study

The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids

Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses

The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain

Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home

Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients

Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine

Opioid Switching in Patients With Advanced Cancer Followed at Home. A Retrospective Analysis

Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

Suchergebnisse filtern